Drug Information services-an Emerging Practice in India A Review

Similar documents
Pharmacologyonline 2: (2010) Newsletter Narain et al.

Drug Information Centre (DIC)-An Indian Scenario

DRUG UTILIZATION STUDIES TO GUIDE BETTER HOSPITAL PHARMACEUTICAL POLICY

Dr. Jacob Roy Kuriakose, Chairman, Alzheimer s Disease International

IDA and the concept of essential drugs

International Journal of Basic & Clinical Pharmacology. Preference for utilization of drug information sources among postgraduate medical residents

USE OF MEDICAL DATABASES BY THE FACULTY AND RESEARCHERS OF SPEECH AND HEARING INSTITUTIONS IN INDIA: A STUDY

MEETING OF DRUGS TECHNICAL ADVISORY BOARD HELD ON 1 ST APRIL, 2014 IN THE CHAMBER OF DGHS, NIRMAN BHAWAN, NEW DELHI

Strategic Plan - Jan Dec 16 (southasia.cochrane.org)

GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE

PDF of Trial CTRI Website URL -

SLEEP AIDS - LABELLING STANDARD

Inflammatory Bowel Disease Output from India: A Scientometric Assessment of Publications during

COPYRIGHTED MATERIAL. Introduction

Book Review: The Role of Education in the Rational use of Medicines

Medicines regulation - National

PREVENTION AND EARLY DETECTION OF CANCER. Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:

Ph.D. (Audiology and Speech, Language Pathology), Sri Ramachandra University, Chennai (2016).

PGEU GPUE. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

Assessment of Medication-Related Problems in Geriatric Patients of a Rural Tertiary Care Hospital

Need of Medicines Information OPD in Tertiary Health Care Settings: A Cross Sectional Study

I am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the

A Study Pattern of Medico-legal Cases Treated at a Tertiary Care Hospital in Central Karnataka

Rare Books & Special Collection of Library

IJEMR December Vol 7 Issue 12 - Online - ISSN Print - ISSN

ULTRAPROCT OINTMENT ULTRAPROCT SUPPOSITORIES

RIJEB Volume 1, Issue 12(December 2012) ISSN: Research Consortium RIJEB RADIX INTERNATIONAL JOURNAL OF ECONOMICS & BUSINESS MANAGEMENT

PATTERN OF ADVERSE DRUG REACTION RELATED QUERIES RECEIVED BY THE DRUG INFORMATION CENTRE OF A TERTIARY CARE TEACHING HOSPITAL

The Challenging and Critical Role of Information Professionals in Combating AIDS in India

Drug Use Indicators. Dr Olayinka Ogunleye Consultant Physician/Clinical Pharmacologist Department of Medicine, LASUTH, Ikeja, LAGOS

Royal College of Physicians, Committee on Ethical Issues in Medicine

Evaluation Of The Rationality Of Claims Made In Drug Promotional Literature In West Chennai. Chennai. Dr. PAVITHIRA SEKAR 2 nd


P. Nasurudeen, Anil Kuruvila, R. Sendhil and V. Chandresekar*

Report. Uganda Pharmaceutical Sector Scan JUNE 2010

Thailand s experience in developing the Reclassification guideline

Addressing the Social Determinants of Health Challenges and Pathways

CHAPTER 3 RESEARCH METHODOLOGY

WHO Country Cooperation Strategy

Clinical Pharmacology and Therapeutics

HEALTHCARE OF ELDERLY PEOPLE. Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:

Mahila Samakhya: A path to empower women?

An Audit of Prescribing Practices in CGHS Dispensaries of Kolkata, India

Physicians Perception of Drug Information Resources in the Emirate of Abu Dhabi-UAE *

Haryana-06 Delhi-07 Total disabled population Persons 455, , , ,886 13, ,454 Males 273, ,908 68, ,872 8, ,44

Test Bank for Basic Pharmacology for Nurses 14th edition by Clayton, Stock and Harroun

Technical matters: Traditional medicine: Delhi Declaration

Assistant Professor, Department of Sociology, Bharathidasan University, Tiruchchirappalli March, Till Date

New Drugs Division. Frequently Asked Questions (FAQs) on Approval of new Phytopharmaceutical Drugs

Adepu and Adusumilli: Drug-related Problems in Patients with Chronic Diseases in South India

ISSN X (Print) Original Research Article. DOI: /sjams

SUMMARY OF THE DIABETIC RETINOPATHY AND RETINOPATHY OF PREMATURITY INITIATIVES IN INDIA MID-TERM REVIEW

Johny Augustine, MSW, M.Phil, Ph.D. 518 West Locust Street Davenport, IA (563)

MEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO

Ayurvedic Treatment for Migraine Pharmaceutical perspective. Clinic to Concept. (Positivism) A Scientific Model

Scientific Program for Biodosimetry Workshop. Day 1: Thursday 4 th October, 2018 Venue: Physiology Demo Room 1

prototypes from the myriad conventional drug classes. In addition, the ND must thoroughly understand the pharmacology of all natural substances.

DOI: /HAS/AJHS/11.1/

Guidance on Bulk Prescribing for Care Home Patients

Gender Inequality in Terms of Health and Nutrition in India: Evidence from National Family Health Survey-3

Department of Palliative Medicine

Division of pharmaceutical sciences, Shri Guru Ram Rai Institute of Technology & Science, Dehradun;

Structure of Postgraduate Training in Radiotherapy in India. Dr. G.K. Rath. Professor & Head Department of Radiation Oncology AIIMS, New Delhi

An Economic Analysis of Changes in the Per Capita Nutrient Intake and Nutritional Inadequacy in Tamil Nadu, India

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

LETTERS FOR ISSUE ON

Tri Pushp Pharma.

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS

CURRICULUM VITAE. : Flat no.6, Mallika, Makarand Society, Savarkar Marg, Mahim, Mumbai , India

PDF of Trial CTRI Website URL -

WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract Research Organization

Framework for Changing Drug Use Practices

Review Article ISSN: Open Access. Regulatory Aspects of Pharmaceutical Excipients in India and their Qualification to Use in Pharmaceuticals

PDF of Trial CTRI Website URL -

IJBCP International Journal of Basic & Clinical Pharmacology

Dr.N.G.P Arts and Science College. Kalapatti Road, Coimbatore RIFF. Department of Medical Physics Issue II Private Circulation Only

LETTERS FOR ISSUE ON

DR SAJJAD ABDUR RAHMAN

LETTERS FOR ISSUE ON

POISONS SCHEDULING. Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health

A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP)

1. Funded Research Projects Sources: CSIR, AIIMS, ICMR, DST, WHO, NIH 3. Non Funded Research Projects- 80

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

6.10. NUTRITIONAL STATUS OF TRIBAL POPULATION

Y. W. Francis Lam, Pharm.D. FCCP University of North Texas Health Science Center Grand Round Rx to OTC Switch: Potentials, Challenges, and Initiatives

BRITISH BIOMEDICAL BULLETIN

7.10. NUTRITIONAL STATUS OF TRIBAL POPULATION

India's voice against AIDS. December 2012

Research Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC

Practicality of direct Reporting Of ADRs by Patients

Ageing in India: The Health Issues

NATIONAL HEART FAILURE REGISTRY - ICC

Impact of Availability and Quality of Pharmaceutical Reference Information on Prescribing Habits and Pharmaceutical Expenditure

Disclosure to Promote the Right To Information

Self Help Groups for Women Empowerment: A Study in Kadur City of Karnataka

Indian Pharmacopoeia Commission

IJBCP International Journal of Basic & Clinical Pharmacology

Federation of Saint Kitts and Nevis

States with Authority to Require Nonresident Pharmacies to Report to PMP

The needs and sources of drug information among pharmacists in Hong Kong

Transcription:

Drug Information services-an Emerging Practice in India A Review Mukesh malik Pharmacy Department, Faculty of Shri Ram Murti Smarg College of Engineering, and Technology The UPT. University Uttar Pradesh, INDIA. ADDRESS FOR CORRESPONDENCE Mr. Mukesh Malik Pharmacy Department, Faculty of Shri Ram Murti Smarg College Engineering, Bareilly 243202, INDIA Phone 09305730760 Mukkuindia771@gmail 85

Summary In India the provision of drug information is a new emerging concept, and this article focuses on the development of drug information and clinical pharmacy services since 1992 in various parts of India. At present there are 17 to 18 drug information centers providing clinical pharmacy in India. Few information centers are independent, not attached to hospitals. They provide drug information to many hospitals in their area. When compare to number of hospitals and the population to be served in India, the numbers of information centers are far below what is needed. More hospitals should implement this form of clinical pharmacy practice to promoter outcome among patients. This review article shall focus on overview of Indian drug information centers. The National Human Rights Commission (NHRC) recommended to the Government of India for setting up computerized drug information center in large hospitals for the benefit of all concerned. Core competence and Co- operation among all health care professionals in a health care facility is needed to promote rational drug use Introduction (Indian scenario) India is country with significant drug use problems. Irrational and unnecessary prescribing is common and antibiotic resistance is widespread. These problems are as a result of variety of economic, social, political, occupational, medical and regulatory factors. The most important of these includes: The lack of awareness about the drug information centre The availability of 80,000 plus formulation The national drug policy is industry focused rather than health focused The lack of awareness of principles of rational drug use of drugs amongst doctors and pharmacists The widespread sale of prescription drug over the counter and A high level illiteracy, poverty among patients. The term drug information developed in the early sixties. In 1962, the first drug information was opened at the University of Kentucky Medical Center, in which an area separated from the pharmacy was dedicated in providing drug information. NEED FOR DRUG INFORMATION: In the past, the smaller range of available drugs limited need for drug information but now new drugs and new modalities of the treatment being introduced. There are more than 20,000 biomedical journals available and more than 6,000 journal published every day. It is a Herculean task for health care professional to keep themselves up-to-date with available drug information. In addition, most developing countries like India suffer from lack of adequate drug information due to limited availability of current literature and also poor documentation, poor funding available. The lack of unbiased drug information service in India poses problem and doctors in general get their information from medical representative who obviously are partially biased towards their product. In India, low income levels populations, the multiple health care systems and lack of awareness about the risks and benefits of drug therapy make good clinical pharmacy practice all the more relevant and important. Due to increasing population and limited number of doctors, their practices are loaded and creates too much of stress. As a result, the quality suffers. There is potential of clinical pharmacist to fill this gap. 86

THE STARTS:- The Drug Information Center Karnataka State Pharmacy Council initiated an independent drug information center on 1997. This center provides unbiased drug information to more than 30-40 hospitals and general practitioners of Bangalore city and some hospitals in Karnataka. The center also monitors ADRs. In coordination with Delhi society for promotion of rational use of drugs (DSPRUD which is supported by WHO India) the Karnataka center produced standard treatment guideline and an essential drug list for Karnataka. LIST OF INDIAN DRUG INFORMATION CENTER AND CLINICAL PHARMACY DEPARTMENT Independent drug information CDMU Documentation Center, Calcutta Drug Information Center, Maharashtra State Pharmacy Council, Maharashtra Andhra Pradesh State Pharmacy Council, Andhra Pradesh Karnataka State Pharmacy Council (KSPC), Bangalore, Karnataka JSS, Ooty, Pharma Information Center, Tamilnadu, Chennai Hospital attached drug information center with clinical pharmacy Christian Medical College Hospital Vellore, Tamilnadu Drug Information Center, (KSPC), Victoria Hospital, Bangalore, Karnataka Drug Information Center, (KSPC), Bowring & Lady Curzon Hospital, Bangalore, Karnataka Department of pharmacy practice, Chidambaram, Tamilnadu Department of Pharmacy Practice, National institute of Pharmaceutical Education and Research (NIPER), Chandigarh Jawaharlal Nehru Medical College Hospital (JNMC), Belgaum, Karnataka JSS, Mysore, Karnataka JSS, Ooty, Tamilnadu N.R.S. Medical College & Hospital, Calcutta Kempagowda Institute of Medical Sciences (KIMS), Bangalore, Karnataka Kasturba Medical College (KMC), Manipal, Karnataka Poison Information Center, All India Institute 87

of Medical Sciences (AIIMS), Delhi Poisons Information Centre, National Institute of Occupational Health, Ahmedabad Dept of Toxicology, (Incl. Poison Information & Laboratory Services) Amrita Institute of Medical Sciences & Research, Cochin Toxicology & IMCU Unit, Government General Hospital, Chennai Sri Ramachandra Hospital, Porur, Chennai Sri Ramakrishna Mission Hospital, Coimbatore, TamilNadu Trivandrum Medical College, Trivandrum, Kerala The Poison information center at All India Institute of Medical Sciences (AIIMS) provides poison information round the clock to hospitals of Delhi and other parts of India. The Institute monitors adverse drugs reaction and reports to Uppsala monitoring center in Swden. Although it is dedicated Poison information center for the country, other drug information center also provide some amount of Poison information to their hospitals. India joined the WHO ADR monitoring in 1998. More of the centers mentioned in this article monitor ADR in their hospital. Centers at J.S.S. and AIIMS sent their reports to Uppsala. Few other centers such as NAZANS at Hyderabad center are or the center at KSPC, Bangalore retains their reports with them. MODUS OPRANDI AND RESOURCES Most of centers operated by pharmacists use IDIS (Iowa Drug Information Services), Medline and Drugdex and from Micro-medex. In independent centres micromedex was found to be very useful in provision of information. The resources available are 1. Primary resources: Primary resources consists of research studies or clinical experience which has not been previously published, they include the results of clinical events such as adverse drug reactions or unexpected clinical outcomes. Examples of journals that publish primary Literatures include Annals of internal medicine, clinical pharmacology and therapeutics etc. (controlled clinical trials, letters to the editor) 88

2. Secondary resources: Secondary resources provide an overview of previously published work include indexing and abstracting services of the primary literature such as IOWA drug information service (IDIS), Medline, International Pharmaceutical Abstracts (IPA), Clinalert and online resources include Pubmed from the National Library of Medicine etc 3. Tertiary sources: These consist of general literature including textbooks and references like American Hospital Formulary Services drug information (AHFS), Martindale the Complete Drug reference, Meyler s side effects of drugs Remington s Pharmaceutical Sciences and United Stated Pharmacopoeia Drug information (USPDI). Tertiary source represents composite, condensed and compact information. While evaluating tertiary literature we should consider expertise and experience of author, correctness of literature, appropriateness of the citations used, clarity, conciseness and ease of use of the literature. Electronic bulletin boards: Electronic bulletin boards are local bulletin boards, which are posted through a server and can be accessed using a computer and a modem. Examples are Clinnet, Pharmline and pharmnet. They expand the ability to monitor therapies recently published or discussed in the media and prevent duplication of drug information searches. Other drug information resources: When queries cannot be answered using the above- mentioned resources, 1. Alternate sources of drug information can be used. They include internet, list serves, local and national, professionals and government organization and pharmaceutical manufacturers. The ability to assess the quality of information obtained from the web is increasingly important for pharmacists not just for their own information but also for the benefit of patients. In order to ensure the quality of information obtained through the web, pharmacy professionals need to be aware of the criteria to evaluate the web as they are for other traditional sources. Some useful Internet Web resources: 1 World Health Organization Library site: http://www.who.int/hlt/virtuallibrary/english/ subject.htm 2. Australian Prescriber: http://www.australianprescriber.com 3. British Medical Journal: http://www.bmj.com/ 4. The Free Medical Journal Site: http://www.freemedicaljournals.com The searching for answering the drug information queries should be in the following order: Tertiary source -> Secondary source -> Primary literature 89

Conclusion Clinical pharmacy and Drug information services are well established in most developed countries. There is not the case of developing countries like India where lack of funds, lack traineds pharmacists, irrational prescribing and poor economics are barriers in establishing well equipped drug information center (DIC). Thepractice of Drug information is currently being developed in India, as can be seen from the table. Successfully DIC implementation is the result of better participation from trained pharmacists and the support of medical professionals. The responsibilities of individual pharmacists for the provision of drug information has increased substantially over the years. Several others factors are stimulating the evaluation of pharmacists as a drug information provider, including information technology changes, knowledge of drug therapy, changing philosophies of pharmacy practice, the education of a pharmacists and a more knowledgeable patient the sophisticated drug therapy offer opportunity to the pharmacist to demonstrate their expertise in providing the appropriate drug information. The world health authorities such as WHO should fund such center to promote the rational use of drugs through providing drug information. Such stimuli are essential for developing countries like India. The National Human Rights Commission (NHRC) recommended to the Government of India for setting up computerized drug information center in large hospitals for the benefit of all concerned. Core competence and Co operation among all health care professionals in a health care facility is needed to promote rational drug use. References 1. Phadke AR, the Quality of Prescribing in an Indian District, National Medical Journal of India, 1996; 9:60-65 2. G.P.Mohanta,Vijayakumar,P.K.Manava,R.Manava,Independent,Unbiased Drug Information a Need to Promote Rational Drug Use Health Administrator Vol:XX Number 1&2: 2005 :99-101 3. Thomas M, Mathai D, Cherian AM, Seshadri MS, Ganesh A, Moses P, Promoting Rational drug Use in India, World Health Forum, 1995; 16:33-35. 4. Lal A, Sethi A, Drug Package Inserts in India (Letter), Ann Pharmcother 1996; 30:1041 5. WHO Policy Perspectives on Medicines Promoting Rational Use of Medicines; Core Components, September 2002, WHO, Geneva 6. Pharmaceutics and Pharmacy Practice, Edited by Gilbert S. Banker and Robert K. Chalmers, J.B. Lippincot Company, Philadelphia, 1982, 155 7. ABC of Rational Use of Medicines, Godwin Nwadibia Aja, Agbo Areo Publishers, Ibadan, 2001, 32. 90